Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Price / Book

Aerie Pharmaceuticals Price / Book Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Price / Book from 2013 to 2020. Price-to-book value (P/B) is the ratio of market value of a company's shares (share price) over its book value of equity. The book value of equity, in turn, is the value of a company's assets expressed on the balance sheet.
  • Aerie Pharmaceuticals Price / Book for the quarter ending December 12, 2020 was 9.86 a 1.90% increase of 0.19 year over year
  • Aerie Pharmaceuticals Price / Book for the last 12 months ending December 12, 2020 was 9.86 a 1.90% increase of 0.19 year over year
  • Aerie Pharmaceuticals Annual Price / Book for 2020 was 9.86 a -0.79% decrease of -0.08 from 2019
  • Aerie Pharmaceuticals Annual Price / Book for 2020 was 9.93 a 2.82% increase of 0.28 from 2019
  • Aerie Pharmaceuticals Annual Price / Book for 2020 was 9.65 a -0.16% decrease of -0.02 from 2019
Other Valuation Metrics:
  • Aerie Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $2,142m a 11.86% increase of 254m year over year
  • Aerie Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $2,017m a 10.53% increase of 212m year over year
View Chart On Koyfin

Quarterly AERI Price / Book Data

12/20209.86
12/20209.93
12/20209.65
11/20209.67
11/202010.13
11/20209.93
11/20209.79
11/20209.55
11/20209.39
11/20209.64

Annual AERI Price / Book Data

20209.86
20209.93
20209.65
20209.67
202010.13
20209.93
20209.79
20209.55
20209.39
20209.64